Press Release Jan 16 2026
Filed with NSE · · 6 pages · English
Enclosed please find press release the Company proposes to issue on unaudited consolidated financial results for the quarter ended on December 31, 2025. SANDEEP ANIL PHADNIS Sandeep Phadnis Vice President - Secretarial & Company Secretary Press Release JB Pharma records revenue growth of 11% to INR 1065 crores in Q3 FY26 # Operating EBITDA increased by 13% to INR 305 crores # Net Profit increases
JB Chemicals & Pharmaceuticals Ltd. on 6ix
In the deck
Earlier from JB Chemicals & Pharmaceuticals
- Press Release Nov 11 2025
- Press Release Jul 30 2025
- Press Release Jun 29 2025
- Press Release May 14 2025
- Press Release Feb 04 2025
Later from JB Chemicals & Pharmaceuticals
All JB Chemicals & Pharmaceuticals news releasesFollow JB Chemicals & Pharmaceuticals into a list and get an email when it puts out news.
Follow JB Chemicals & Pharmaceuticals